Related Experiment Video
Updated: Dec 20, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide
Chia Siang Kow1, Wendy Sunter2, Amie Bain3,4
1School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Insights
The COVID-19 pandemic has disrupted warfarin anticoagulation management. This article presents a stepwise algorithm and alternative strategies to ensure safe and optimized outpatient warfarin therapy during the global health crisis.
Area of Science:
- Pharmacology
- Internal Medicine
- Public Health
Background:
- COVID-19 pandemic has significantly impacted healthcare resource allocation.
- Management of patients on warfarin therapy may be compromised due to pandemic-related disruptions.
- Maintaining effective anticoagulation is crucial for preventing thrombotic events.
Purpose of the Study:
- To provide a stepwise algorithm for managing outpatient warfarin therapy during the COVID-19 pandemic.
- To discuss alternative management strategies, including pharmacological options and self-monitoring.
- To assist clinicians in optimizing anticoagulation treatment for patients amidst the global health crisis.
Main Methods:
- Review and synthesis of current literature on warfarin management and COVID-19 impact.
- Development of a structured, stepwise clinical algorithm.
- Discussion of evidence supporting alternative anticoagulation therapies and self-monitoring approaches.
Main Results:
- A clear, actionable algorithm for outpatient warfarin management is proposed.
- Alternative pharmacological agents and self-monitoring techniques are evaluated for safety and efficacy.
- Strategies aim to mitigate risks associated with disrupted warfarin care.
Conclusions:
- The proposed algorithm offers a framework for safe and effective outpatient warfarin management during the pandemic.
- Alternative strategies like novel oral anticoagulants and patient self-testing can support continued anticoagulation.
- Proactive management is essential to prevent adverse events and ensure patient safety in anticoagulation therapy.
Abstract:
Many healthcare resources have been and continue to be allocated to the management of patients with COVID-19. Therefore, the ongoing care of patients receiving oral anticoagulation with warfarin is likely to be compromised amid this unprecedented crisis. This article discusses a stepwise algorithm for the management of outpatient warfarin therapy. Alternative management strategies are presented and discussed, including alternative pharmacological therapy options and self-monitoring. Our algorithm aims to help clinicians safely optimize the treatment of patients requiring anticoagulation therapy in the context of the global response to the current pandemic.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management

